EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

Phase 2

Active, not recruiting

Conditions: Glioblastoma
Gliosarcoma

Interventions: Radiation: Dose-Escalated Radiation Therapy
Procedure: Spectroscopic Magnetic Resonance Imaging
Drug: Temozolomide

First Posted Date: 2017-05-03

Last Posted Date: 2024-02-13

Lead Sponsor: Emory University

Target Recruit Count: 34

Registration Number: NCT03137888

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
🇺🇸
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer

Phase 2

Withdrawn

Conditions: Stage IV Non-Small Cell Lung Cancer
Recurrent Non-Small Cell Lung Carcinoma

Interventions: Biological: Nivolumab

First Posted Date: 2017-04-20

Last Posted Date: 2019-05-21

Lead Sponsor: Emory University

Registration Number: NCT03121417

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Phase 1

Completed

Conditions: Stage IVB Colorectal Cancer
Stage IVB Pancreatic Cancer
Unresectable Pancreatic Carcinoma
Colorectal Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Recurrent Colorectal Carcinoma
Recurrent Pancreatic Carcinoma
Stage III Colorectal Cancer
Stage III Pancreatic Cancer
Stage IIIA Colorectal Cancer

Interventions: Drug: XL888
Biological: Pembrolizumab

First Posted Date: 2017-03-30

Last Posted Date: 2023-12-05

Lead Sponsor: Emory University

Target Recruit Count: 49

Registration Number: NCT03095781

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

Cryoablation for Obesity Management

Not Applicable

Completed

Conditions: Obesity

Interventions: Procedure: Cryoablation

First Posted Date: 2017-03-28

Last Posted Date: 2018-10-31

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT03092778

Locations: 🇺🇸
Emory St. Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Johns Creek Hospital, Johns Creek, Georgia, United States

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Not Applicable

Withdrawn

Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Leukemia
Myelodysplastic Syndrome
Anemia
Bone Marrow Failure
Aplastic Anemia

Interventions: Procedure: Red Blood Cell Transfusions (RBCT)

First Posted Date: 2017-03-22

Last Posted Date: 2018-07-26

Lead Sponsor: Emory University

Registration Number: NCT03086252

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Device: Standard Catheter-Directed Thrombolysis
Device: Ultrasound-Accelerated Thrombolysis

First Posted Date: 2017-03-22

Last Posted Date: 2023-06-27

Lead Sponsor: Emory University

Target Recruit Count: 18

Registration Number: NCT03086317

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States

and more 1 locations

Faith-Based African American Cancer Survivorship Storytelling

Not Applicable

Completed

Conditions: Cancer

Interventions: Behavioral: Faith-Based African American Cancer Survivorship Storytelling Intervention

First Posted Date: 2017-03-17

Last Posted Date: 2023-10-05

Lead Sponsor: Emory University

Target Recruit Count: 22

Registration Number: NCT03082612

Locations: 🇺🇸
Grady Cancer Center for Excellence, Atlanta, Georgia, United States

Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease

Phase 2

Completed

Conditions: Cancer

Interventions: Drug: FACBC PET-CT Imaging

First Posted Date: 2017-03-16

Last Posted Date: 2021-01-25

Lead Sponsor: Emory University

Target Recruit Count: 61

Registration Number: NCT03081884

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy

Not Applicable

Completed

Conditions: Plasma Cell Myeloma

Interventions: Device: Jamshidi needle
Device: Power drill

First Posted Date: 2017-03-13

Last Posted Date: 2024-05-17

Lead Sponsor: Emory University

Target Recruit Count: 97

Registration Number: NCT03078452

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

The Impact of Enhanced, Demand-side Sanitation and Hygiene Promotion on Sustained Behavior Change and Health in Ethiopia

Not Applicable

Completed

Conditions: Sustained Behavior Change
Mental Well-being

Interventions: Behavioral: Enhanced demand-side sanitation, hygiene
Behavioral: Standard of care

First Posted Date: 2017-03-09

Last Posted Date: 2019-07-05

Lead Sponsor: Emory University

Target Recruit Count: 10375

Registration Number: NCT03075436

Locations: 🇪🇹
Amhara, Amhara National Regional State, Ethiopia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy